Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc.verified

BLCM

Price:

$0.07475

Market Cap:

$778.33K

Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an ...[Read more]

Industry

Biotechnology

IPO Date

2014-12-18

Stock Exchange

NASDAQ

Ticker

BLCM

The ROE as of December 2024 (TTM) for Bellicum Pharmaceuticals, Inc. (BLCM) is 33.22%

According to Bellicum Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 33.22%. This represents a change of -167.72% compared to the average of -49.06% of the last 4 quarters.

Bellicum Pharmaceuticals, Inc. (BLCM) Historical ROE (quarterly & annually)

How has BLCM ROE performed in the past?

The mean historical ROE of Bellicum Pharmaceuticals, Inc. over the last ten years is -82.32%. The current 33.22% ROE has changed -140.36% with respect to the historical average. Over the past ten years (40 quarters), BLCM's ROE was at its highest in in the December 2019 quarter at 110.54%. The ROE was at its lowest in in the September 2019 quarter at -2606.35%.

Quarterly (TTM)
Annual

Average

-82.32%

Median

-41.54%

Minimum

-1239.35%

Maximum

480.96%

Bellicum Pharmaceuticals, Inc. (BLCM) ROE by Quarter and Year

Discovering the peaks and valleys of Bellicum Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 3.06%

Maximum Annual ROE = 480.96%

Minimum Annual Increase = -435.95%

Minimum Annual ROE = -1239.35%

Quarterly (TTM)
Annual
YearROEChange
2022-1239.35%3.06%
2021-39.26%-111.37%
2020345.17%-28.23%
2019480.96%-435.95%
2018-143.16%32.04%
2017-108.42%51.22%
2016-71.70%124.50%
2015-31.94%-27.11%
2014-43.81%-254.79%
201328.31%-11.99%

Bellicum Pharmaceuticals, Inc. (BLCM) Average ROE

How has BLCM ROE performed in the past?

The current ROE of Bellicum Pharmaceuticals, Inc. (BLCM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-311.15%

5-year avg

-119.13%

10-year avg

-82.32%

Bellicum Pharmaceuticals, Inc. (BLCM) ROE vs. Peers

How is BLCM’s ROE compared to its peers?

Bellicum Pharmaceuticals, Inc.’s ROE is greater than Cellectis S.A. (-75.49%), greater than Adaptimmune Therapeutics plc (-74.84%), less than Calithera Biosciences, Inc. (8.01%), less than Atara Biotherapeutics, Inc. (965.52%), greater than Affimed N.V. (-193.85%),

Build a custom stock screener for Bellicum Pharmaceuticals, Inc. (BLCM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellicum Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bellicum Pharmaceuticals, Inc. (BLCM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bellicum Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Bellicum Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Bellicum Pharmaceuticals, Inc. (BLCM)?

What is the highest ROE for Bellicum Pharmaceuticals, Inc. (BLCM)?

What is the 3-year average ROE for Bellicum Pharmaceuticals, Inc. (BLCM)?

What is the 5-year average ROE for Bellicum Pharmaceuticals, Inc. (BLCM)?

How does the current ROE for Bellicum Pharmaceuticals, Inc. (BLCM) compare to its historical average?